Autres langues Agios Pharmaceuticals, Inc.

Actions

AGIO

US00847X1046

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
34,54 ^USD	-0,12%		+9,69%	+55,10%

02/05	Les actions d'Agios Pharmaceuticals augmentent après la publication d'une perte plus faible au premier trimestre	MT
02/05	Transcript : Agios Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024	03/05
Agios Pharmaceuticals Shares Rise After Reporting Smaller Q1 Loss	02/05
Agios Pharmaceuticals : First Quarter 2024 Financial Results Presentation	02/05
Agios Pharmaceuticals: Q1 Earnings Snapshot	02/05
Earnings Flash (AGIO) AGIOS PHARMACEUTICALS Reports Q1 Revenue $8.2M	02/05
Agios Reports Business Highlights and First Quarter 2024 Financial Results	02/05
Agios Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024	18/04
Agios Publishes 2024 Environmental, Social and Governance Report	10/04
Agios Publishes 2024 Environmental, Social and Governance (ESG) Report	09/04
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	06/03
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024	05/03
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024	22/02
Agios Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Agios Pharmaceuticals 2023 Loss Widens, Revenue Rises	15/02
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights	15/02
Agios Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024	02/02
Agios Pharmaceuticals Insider Sold Shares Worth $277,397, According to a Recent SEC Filing	09/01
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio	08/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Agios Pharmaceuticals, Inc.

Actions

AGIO

US00847X1046

Autres langues

Filtres